Skip to main content
Top
Published in: International Journal of Clinical Oncology 3/2014

01-06-2014 | Original Article

High incidence of regional and in-transit lymph node metastasis in patients with alveolar rhabdomyosarcoma

Authors: Yoshihiro Nishida, Satoshi Tsukushi, Hiroshi Urakawa, Hideshi Sugiura, Hiroatsu Nakashima, Yoshihisa Yamada, Naoki Ishiguro

Published in: International Journal of Clinical Oncology | Issue 3/2014

Login to get access

Abstract

Background

Rhabdomyosarcoma has different extension patterns, including a higher propensity for lymph nodes metastasis, compared with other types of soft tissue sarcoma. The aims of this study were to investigate the patterns of regional and distant metastasis in patients with rhabdomyosarcomas, particularly lymphatic route metastasis, and clarify the clinical factors that affect the pattern of metastasis.

Methods

Forty-four patients with rhabdomyosarcomas were enrolled in this study. The mean age of the patients was 26 (range 1–69) years, and 18 were males. The histological subtypes included alveolar (17 patients), embryonal (10 patients), pleomorphic (7 patients), and unknown (10 patients). Based on location, the sarcomas were divided into three groups: extremity (17 cases), favorable prognosis (10 cases), and unfavorable prognosis (15 cases). There were three cases (7 %) of local relapse, ten cases of regional lymph node relapse, and three cases of in-transit metastasis (total 30 %). Twenty-one patients (48 %) developed distant metastases. Initial sites of metastases were bone (9 patients, 20 %), lung (5 patients), and bone marrow dissemination (5 patients). Clinico-pathological variables affecting relapse patterns were analyzed.

Results

Of the three cases of local relapse, two were alveolar type and one was unknown. The three cases of in-transit metastasis were all alveolar type. Patients with alveolar type had a significantly high propensity for lymph node metastasis (P = 0.027). Excluding the pleomorphic type, alveolar type was still a significant factor for lymph node metastasis (P = 0.017).

Conclusion

Physicians should be aware of in-transit spread, particularly in patients with alveolar-type rhabdomyosarcoma. Novel treatment modalities are required to detect and treat in-transit metastasis.
Literature
1.
go back to reference Crist WM, Anderson JR, Meza JL et al (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol official J Am Soc Clin Oncol 19:3091–3102 Crist WM, Anderson JR, Meza JL et al (2001) Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol official J Am Soc Clin Oncol 19:3091–3102
2.
go back to reference Pappo AS, Anderson JR, Crist WM et al (1999) Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol Off J Am Soc Clin Oncol 17:3487–3493 Pappo AS, Anderson JR, Crist WM et al (1999) Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group. J Clin Oncol Off J Am Soc Clin Oncol 17:3487–3493
3.
go back to reference Stevens MC, Rey A, Bouvet N et al (2005) Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology–SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol Off J Am Soc Clin Oncol 23:2618–2628. doi:10.1200/JCO.2005.08.130 CrossRef Stevens MC, Rey A, Bouvet N et al (2005) Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology–SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol Off J Am Soc Clin Oncol 23:2618–2628. doi:10.​1200/​JCO.​2005.​08.​130 CrossRef
4.
go back to reference Joshi D, Anderson JR, Paidas C et al (2004) Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Pediatr Blood Cancer 42:64–73. doi:10.1002/pbc.10441 PubMedCrossRef Joshi D, Anderson JR, Paidas C et al (2004) Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Pediatr Blood Cancer 42:64–73. doi:10.​1002/​pbc.​10441 PubMedCrossRef
5.
go back to reference Oberlin O, Rey A, Lyden E et al (2008) Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol Off J Am Soc Clin Oncol 26:2384–2389. doi:10.1200/JCO.2007.14.7207 CrossRef Oberlin O, Rey A, Lyden E et al (2008) Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol Off J Am Soc Clin Oncol 26:2384–2389. doi:10.​1200/​JCO.​2007.​14.​7207 CrossRef
6.
go back to reference Carli M, Colombatti R, Oberlin O et al (2004) European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol Off J Am Soc Clin Oncol 22:4787–4794. doi:10.1200/JCO.2004.04.083 CrossRef Carli M, Colombatti R, Oberlin O et al (2004) European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. J Clin Oncol Off J Am Soc Clin Oncol 22:4787–4794. doi:10.​1200/​JCO.​2004.​04.​083 CrossRef
7.
go back to reference Neville HL, Andrassy RJ, Lobe TE et al (2000) Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991–1997). J Pediatr Surg 35:317–321PubMedCrossRef Neville HL, Andrassy RJ, Lobe TE et al (2000) Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991–1997). J Pediatr Surg 35:317–321PubMedCrossRef
9.
go back to reference Nishida Y, Tsukushi S, Urakawa H et al (2011) Difficulties to detect in-transit lymphatic metastasis in patients with rhabdomyosarcoma of the extremity: in regard to La et al. (Int J Radiat Oncol Biol Phys 2011;80:1151–1157). Int J Radiat Oncol Biol Phys 81:606; author reply 606. doi:10.1016/j.ijrobp.2011.04.061 Nishida Y, Tsukushi S, Urakawa H et al (2011) Difficulties to detect in-transit lymphatic metastasis in patients with rhabdomyosarcoma of the extremity: in regard to La et al. (Int J Radiat Oncol Biol Phys 2011;80:1151–1157). Int J Radiat Oncol Biol Phys 81:606; author reply 606. doi:10.​1016/​j.​ijrobp.​2011.​04.​061
10.
go back to reference Nishida Y, Tsukushi S, Yamada Y et al (2011) Recurrent alveolar rhabdomyosarcoma with prior surgery and radiotherapy: altered lymphatic drainage limits the reliability of sentinel lymph node biopsy. J Pediatr Hematol Oncol 33:e26–e28. doi:10.1097/MPH.0b013e3181faf857 PubMedCrossRef Nishida Y, Tsukushi S, Yamada Y et al (2011) Recurrent alveolar rhabdomyosarcoma with prior surgery and radiotherapy: altered lymphatic drainage limits the reliability of sentinel lymph node biopsy. J Pediatr Hematol Oncol 33:e26–e28. doi:10.​1097/​MPH.​0b013e3181faf857​ PubMedCrossRef
11.
13.
go back to reference Nishida Y, Yamada Y, Tsukushi S et al (2005) Sentinel lymph node biopsy reveals a positive popliteal node in clear cell sarcoma. Anticancer Res 25:4413–4416PubMed Nishida Y, Yamada Y, Tsukushi S et al (2005) Sentinel lymph node biopsy reveals a positive popliteal node in clear cell sarcoma. Anticancer Res 25:4413–4416PubMed
14.
go back to reference Volker T, Denecke T, Steffen I et al (2007) Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol Off J Am Soc Clin Oncol 25:5435–5441. doi:10.1200/JCO.2007.12.2473 CrossRef Volker T, Denecke T, Steffen I et al (2007) Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol Off J Am Soc Clin Oncol 25:5435–5441. doi:10.​1200/​JCO.​2007.​12.​2473 CrossRef
17.
go back to reference Chisholm JC, Marandet J, Rey A et al (2011) Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy. J Clin Oncol Off J Am Soc Clin Oncol 29:1319–1325. doi:10.1200/JCO.2010.32.1984 CrossRef Chisholm JC, Marandet J, Rey A et al (2011) Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy. J Clin Oncol Off J Am Soc Clin Oncol 29:1319–1325. doi:10.​1200/​JCO.​2010.​32.​1984 CrossRef
18.
go back to reference Dantonello TM, Int-Veen C, Winkler P et al (2008) Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. J Clin Oncol Off J Am Soc Clin Oncol 26:406–413. doi:10.1200/JCO.2007.12.2382 CrossRef Dantonello TM, Int-Veen C, Winkler P et al (2008) Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. J Clin Oncol Off J Am Soc Clin Oncol 26:406–413. doi:10.​1200/​JCO.​2007.​12.​2382 CrossRef
19.
go back to reference Wharam MD, Meza J, Anderson J et al (2004) Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. J Clin Oncol Off J Am Soc Clin Oncol 22:1902–1908. doi:10.1200/JCO.2004.08.124 CrossRef Wharam MD, Meza J, Anderson J et al (2004) Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study. J Clin Oncol Off J Am Soc Clin Oncol 22:1902–1908. doi:10.​1200/​JCO.​2004.​08.​124 CrossRef
20.
go back to reference Rodeberg DA, Garcia-Henriquez N, Lyden ER et al (2011) Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children’s Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol 29:1304–1311. doi:10.1200/JCO.2010.29.4611 CrossRef Rodeberg DA, Garcia-Henriquez N, Lyden ER et al (2011) Prognostic significance and tumor biology of regional lymph node disease in patients with rhabdomyosarcoma: a report from the Children’s Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol 29:1304–1311. doi:10.​1200/​JCO.​2010.​29.​4611 CrossRef
22.
go back to reference McMulkin HM, Yanchar NL, Fernandez CV et al (2003) Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma. Pediatr Surg Int 19:453–456. doi:10.1007/s00383-003-0956-y PubMedCrossRef McMulkin HM, Yanchar NL, Fernandez CV et al (2003) Sentinel lymph node mapping and biopsy: a potentially valuable tool in the management of childhood extremity rhabdomyosarcoma. Pediatr Surg Int 19:453–456. doi:10.​1007/​s00383-003-0956-y PubMedCrossRef
23.
go back to reference Mazzoleni S, Bisogno G, Garaventa A et al (2005) Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma. Cancer 104:183–190. doi:10.1002/cncr.21138 PubMedCrossRef Mazzoleni S, Bisogno G, Garaventa A et al (2005) Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma. Cancer 104:183–190. doi:10.​1002/​cncr.​21138 PubMedCrossRef
24.
go back to reference Meza JL, Anderson J, Pappo AS et al (2006) Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children’s Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol 24:3844–3851. doi:10.1200/JCO.2005.05.3801 CrossRef Meza JL, Anderson J, Pappo AS et al (2006) Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children’s Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol 24:3844–3851. doi:10.​1200/​JCO.​2005.​05.​3801 CrossRef
Metadata
Title
High incidence of regional and in-transit lymph node metastasis in patients with alveolar rhabdomyosarcoma
Authors
Yoshihiro Nishida
Satoshi Tsukushi
Hiroshi Urakawa
Hideshi Sugiura
Hiroatsu Nakashima
Yoshihisa Yamada
Naoki Ishiguro
Publication date
01-06-2014
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 3/2014
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-013-0571-4

Other articles of this Issue 3/2014

International Journal of Clinical Oncology 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine